患有莱维体的痴呆症:基因组学,转录组学及其数据科学未来
Thomas R Goddard1, Keeley J Brookes2, Riddhi Sharma3,4
1Mental Health and Clinical Neurosciences Academic Unit, Institute of Mental Health, School of Medicine, University of Nottingham, Nottingham NG7 2TU, UK.
Cells
|February 9, 2024
概括
莱维体痴呆症 (DLB) 研究需要更好的数据科学. 先进的基因组和转录组分析可以揭示疾病修饰治疗和生物标志物的新见解.
科学领域:
- 神经退行性疾病的神经退行性疾病
- 基因组学和转录基因组学
- 医学中的数据科学.
背景情况:
- 勒维体痴呆症 (DLB) 是第二常见的神经退行性痴呆症,其特征是严重的神经精神症状.
- 已知的遗传变异 (例如,SNCA,GBA,APOE) 和转录基因特征 (例如,同核素聚合,神经炎症) 提供了对DLB病理学的部分见解.
- 目前的理解是不完整的,导致缺乏改变疾病的治疗方法和诊断生物标志物.
研究的目的:
- 审查目前对DLB的基因组和转录组理解.
- 确定有关DLB分子病理学的现有文献中的空白.
- 探索数据科学方法在推动DLB研究和治疗方面的潜力.
主要方法:
- 在DLB中审查现有的基因组和转录组研究.
- 对已识别的遗传变异和转录基因签名进行分析.
- 讨论数据科学方法,包括机器学习和多原子数据分析.
主要成果:
- 基因组研究发现了与SNCA,GBA,APOE,SNCB和MAPT变异的关联.
- 转录组分析揭示了与蛋白质聚合,神经炎症和线粒体功能障碍相关的签名.
- 在了解DLB分子病理学方面仍然存在重大差距.
结论:
- 数据科学方法,包括全转录组分析和对多原子数据的机器学习,有望揭示新的DLB签名.
- 基因组预测可以实现早期病例识别和及时治疗.
- 通过数据科学推进DLB的理解对于开发有效的疗法和生物标志物至关重要.
相关概念视频
01:30Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
03:00Next-generation Sequencing
88.8K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.8K
02:02Genomics
36.3K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
36.3K
01:11Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
01:26Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484